CARR Biosystems

1 day ago | cellandgene.com | Erin Harris |Dan Nelson |CARR Biosystems |Royce Tourtillott

Setting the Standard in CGT: Perspectives on Performance, Scalability, and Regulatory ComplianceExplore the evolving landscape of cell and gene therapy with insights from key opinion leaders. This white paper addresses challenges in process development and manufacturing across different modalities. Discover how end-to-end solutions can accelerate commercialization by prioritizing performance and scalability while simplifying the path to regulatory approvals.

1 month ago | bioprocessonline.com | Tyler Menichiello |Dan Nelson |CARR Biosystems |Khalil D. Essani

The rapid advance of ADCs has tested the fine balance between speed to IND and process development that stands up to the rigors of scale-up and transfer. Explore the processes leading ADC developers are employing to mitigate manufacturing-scale risk, and how automation and artificial intelligence are beginning to inform their work. Join Bioprocess Online Live for this interactive discussion. Registration is free thanks to the support of Thermo Fisher Scientific.